Chargement en cours...
Splicing variants of androgen receptor in prostate cancer
Significant advances in our understanding of continued androgen receptor (AR) signaling in castration-resistant prostate cancer have led to the development and FDA approval of two next-generation androgen-directed therapies, abiraterone and enzalutamide. These new therapies heralded a new era of pro...
Enregistré dans:
| Publié dans: | Am J Clin Exp Urol |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
e-Century Publishing Corporation
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4219285/ https://ncbi.nlm.nih.gov/pubmed/25374896 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|